Expansion Opportunity Significant planned investment in Rock Hill, South Carolina with a $1.5B project to build a U.S. headquarters and manufacturing campus, plus a large job creation target. This indicates a needs window for capacity equipment, facility construction services, plasma processing systems, and ongoing pharma manufacturing support.

Capacity Expansion Rock Hill site aims to add 3.5 million liters of plasma processing capacity, representing a major scale-up in production capability. Opportunities exist for plasma collection optimization, bioprocessing technologies, quality control systems, and supply chain/logistics partnerships to support higher throughput.

Talent & Site Large local hiring and relocation of hundreds of skilled roles imply demand for workforce development, technical training services, employee health and safety solutions, and facility services to sustain expanded operations and compliance.

Global Footprint Octapharma operates across 120 countries with multiple R&D and manufacturing sites, suggesting potential for regional partnerships in clinical development, regulatory affairs support, and cross-border supply chain optimization, especially in critical care and immunotherapy therapies.

Technology Stack Use of Azure Synapse Analytics, Microsoft Azure SQL Database, and BPMN indicates openness to cloud-based data integration, manufacturing analytics, and process automation. Potential upsell for data modernization, analytics, MES/ERP integrations, and cybersecurity solutions to support scalable operations.